Abstract
Objective To assess whether home-based, self-applied cognitive training combined with tDCS in older adults is feasible (primary), acceptable, and effective (secondary).
Design Monocentric, double-blind, randomized (1:1), controlled trial conducted from May 2021 to July 2023, involving six at-home sessions and pre-, post- and follow-up assessments in the laboratory.
Setting University Medicine Greifswald and participants’ homes.
Participants Thirty older adults (60-80 years), randomized to anodal or sham tDCS group (n = 15 each).
Interventions Six sessions at home over the course of two weeks (three per week) with training of letter updating and concurrent self-applied tDCS (1.5 mA, 20 min/30 s). Participants were thoroughly trained in self-application of the stimulation and handling of the material.
Main outcomes measures The primary outcome was feasibility, operationalized by successfully performed interventional sessions per participant. Four or more out of six sessions successfully performed in at least 60% of all participants were defined for the trial to be deemed feasible. Secondary outcomes included: acceptability assessed via questionnaire and cognitive performance on training and transfer tasks.
Results 29 participants successfully completed four or more out of six intervention sessions (96.7%, 95%-CI: [81.9, 100.0]), confirming the feasibility of the intervention (primary outcome). Overall satisfaction with the intervention and mean feasibility rating was high (93%, 95%-CI: [77.6 to 99.2]). Training (letter updating) task performance was superior in the target compared to the control group (β = 3.5, 95%-CI: [0.5 to 6.6], p = 0.037). There was no substantial difference in the transfer (N-back) task (β = -5.1, 95%-CI: [-14.6 to 4.5], p = 0.23).
Conclusions Self-administered, home-based combination of cognitive training and tDCS is feasible and acceptable in older adults. Pre-defined secondary outcomes indicate superior cognitive enhancement of the trained function in the active stimulation group. Our study indicates that a Phase III trial is now warranted.
Trial registration Prospectively registered (clinicalTrials.gov, NCT04817124).
What is known about this topic
Effective interventions for age-related cognitive decline are not available and constitute a major unmet medical need
Combining cognitive training with transcranial direct current stimulation (tDCS) is a safe, low-cost, and potentially effective approach for treating age-related cognitive decline, but currently used laboratory-based interventions over extended periods are time-consuming and laborious for both clinicians and patients, and thus not feasible in routine care.
Feasibility, acceptability and efficacy of home-based, self-administered tDCS combined with cognitive training in older adults still need to be determined.
What this study adds
This study demonstrates that home-based, self-administered tDCS combined with cognitive training is feasible, acceptable and potentially effective for enhancing cognitive functions in older adults.
Our findings pave the way for a subsequent Phase III clinical trial to provide high-level evidence for clinical efficacy of this approach.
Competing Interest Statement
The authors have declared no competing interest.
Clinical Trial
NCT04817124
Funding Statement
Funding for this study was provided by Bundesministerium fuer Bildung und Forschung (FKZ 01GQ1424A). This work was supported by the Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) Project number 327654276, SFB 1315 to AF. CTLL is a PhD fellow funded by the Deutscher Akademischer Austauschdienst (DAAD) [scholarship: 91828451].
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Ethics committee of the University Medicine Greifswald gave ethical approval of this work.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Footnotes
↵* Shared-last authorship
Data Availability
All data produced in the present study are available upon reasonable request to the authors.
